简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2015-11-10 09:58 Replicor Announces Grant of US Patents on HBV / HDV Treatment Methods Combining HBsAg Reduction and Immunotherapy
2015-11-09 16:58 Takeda to Present Data from Ixazomib’s Phase 3 Study in Relapsed/Refractory Multiple Myeloma at Upcoming American Society of Hematology Annual Meeting
2015-11-09 16:51 Founder Dennis Gillings to Retire as Quintiles Executive Chairman at Close of 2015
2015-11-09 14:45 Research Finds Cranberries are an Effective Approach to Help Reduce Antibiotic Use
2015-11-09 10:48 EMPA-REG OUTCOME®: Top-line renal data to be presented during American Society of Nephrology (ASN) Kidney Week 2015
2015-11-06 14:28 Cell Signaling Technology Announces the Release of 6 New Monoclonal Antibodies for Tumor Immunology Research.
2015-11-05 16:05 Pharco Pharmaceuticals, Inc. Announces Late-Breaker Oral Presentation at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2015
2015-11-05 11:10 Merck and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung Cancer
2015-11-05 10:00 Singapore General Hospital and Thermo Fisher Scientific Collaborate to Identify the Prevalence of Asian-Specific Genetic Mutations in Cancer
2015-11-04 15:15 China Food and Drug Administration (CFDA) Grants Approval for Avedro’s KXL® System
2015-11-03 16:31 Boehringer Ingelheim initiates pivotal programme for novel third-generation EGFR targeting lung cancer compound
2015-11-02 18:03 Multi-Stakeholder Study Reveals That Clinical Research Participation Leads to Higher Patient Engagement, Reduced Cost of Care
2015-11-02 16:31 Takeda Reports Results for the First Half of FY2015 Confirms Management Guidance for the Full Year
2015-10-30 15:50 Two New Clinical Studies Using Masimo Technologies Presented at the American Society of Anesthesiologists Annual Meeting
2015-10-29 17:53 Egon Zehnder Announces New Global Health Practice – Egon Zehnder Health
2015-10-29 17:06 Seattle Genetics and Takeda Achieve Target Enrollment in Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (Brentuximab Vedotin) in Previously Untreated Advanced Hodgkin Lymphoma (HL)
2015-10-29 14:29 Terumo BCT Completes the First Clinical Study Reducing Malaria Transmission from Whole Blood Transfusions with Pathogen Reduction Technology
2015-10-29 10:05 Boehringer Ingelheim’s Biosimilar Candidate Demonstrated Pharmacokinetic Bioequivalence to Adalimumab
2015-10-29 09:56 CHEST: New Sub-Analyses Show Improvement in COPD Patient Outcomes with Spiolto® Respimat®
2015-10-28 17:20 Masimo Announces FDA 510(k) Clearance for MightySat™ Rx Fingertip Pulse Oximeter

Business Wire Weibo

Press Releases

Latest Releases